Work

A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials

Year: 2017
Type: article
Source: PMC
Language: English
Open Access status: closed
OpenAlex ID: W2804243729
FWCI:
Cites:
Cited by:
Related to: 20